Clinical Trials Directory

Trials / Sponsors / Xynomic Pharmaceuticals, Inc.

Xynomic Pharmaceuticals, Inc.

Industry · 6 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingXP-102 and XP-102 in Combination With Trametinib in Advanced Solid Tumor Patients With a BRAF V600 Mutation
Cancer, BRAF V600 Mutation, Melanoma
Phase 1 / Phase 22025-12-31
Active Not RecruitingA Multi-Center Phase 2 Study to Evaluate Efficacy and Safety of Oral Abexinostat as Monotherapy in Patients Wi
Lymphoma, Follicular
Phase 22020-04-22
RecruitingStudy to Evaluate Efficacy and Safety of Oral Abexinostat in Patients With Relapsed or Refractory Diffuse Larg
Diffuse Large B-cell Lymphoma (DLBCL)
Phase 22020-01-20
Active Not RecruitingA Clinical Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Abexinostat in Chinese Patients
Non Hodgkin Lymphoma
Phase 1 / Phase 22020-01-08
Active Not RecruitingStudy of Abexinostat in Patients With Relapsed or Refractory Follicular Lymphoma
Follicular Lymphoma
Phase 22018-08-27
RecruitingA Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Ca
Renal Cell Carcinoma
Phase 32018-07-17